Turn Therapeutics (TTRX) Asset Writedowns and Impairment (2026)
Turn Therapeutics' (TTRX) quarterly Asset Writedowns and Impairment came in at $477647.0 in Q1 2026.
Turn Therapeutics (TTRX) Asset Writedowns and Impairment (2026) Analysis & Trends
Turn Therapeutics' Asset Writedowns and Impairment history runs 1 years deep, the most recent figure standing at $477647.0 for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,071.19 Bn | 1,071.19 Bn | - |
| 4 | BeOne Medicines | 469.11 Bn | 464.32 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.03 Bn | 115.78 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.13 Bn | 61.37 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.44 Bn | 63.44 Bn | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Turn Therapeutics | 238.90 Mn | 238.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 477,647.00 |
| Mar 31, 2026 | 477,647.00 |